![Michael Varney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Varney
Technik-/Wissenschafts-/F&E-Leiter bei
ERASCA, INC.
Vermögen: - $ am 30.06.2026
Profil
Michael D.
Varney is Director, Chairman-Research & Development at Erasca, Inc. since 2020.
Lead Independent Director at Numerion Labs, Inc. starting 2025.
Director at Affini-T Therapeutics, Inc. since 2022.
Senior Advisor at Frazier Management LLC since 2020.
Trustee at The California Academy of Sciences.
Former Director at Foundation Medicine, Inc. from 2015 to 2018.
Independent Director at Pardes Biosciences, Inc. from 2021 to 2023.
Head-Research at Agouron Pharmaceuticals LLC from 1987 to 2005.
Executive VP, Head-Research & Early Development at Genentech, Inc. from 2015 to 2020.
Held the position Head-Genentech Research & Early Development at Roche Holding AG.
Vice President-Drug Discovery at Pfizer (St. Louis) from 2000 to 2005.
Education includes an undergraduate degree from the University of California, Los Angeles in 1980 and a doctorate from the California Institute of Technology in 1985.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC. -.--% | 15.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Michael Varney
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Direktor/Vorstandsmitglied | - |
Atomwise, Inc.
 Atomwise, Inc. Packaged SoftwareTechnology Services Develops an AI chemistry super platform that provides unprecedented capabilities for innovative drug hunting | Direktor/Vorstandsmitglied | 17.06.2021 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Berater | 01.01.2020 |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Direktor/Vorstandsmitglied | 05.04.2022 |
Ehemalige bekannte Positionen von Michael Varney
| Unternehmen | Position | Ende |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 30.08.2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| FOUNDATION MEDICINE INC | Direktor/Vorstandsmitglied | 01.03.2018 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
| ░░░░░░ ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Michael Varney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The California Academy of Sciences
The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Commercial Services |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Atomwise, Inc.
Atomwise, Inc. Packaged SoftwareTechnology Services Develops an AI chemistry super platform that provides unprecedented capabilities for innovative drug hunting | Technology Services |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
